R

Reuben J. Shaw

Salk Institute for Biological Studies

ORCID: 0000-0002-1555-8977

Publishes on Lung Cancer Treatments and Mutations, Cancer, Hypoxia, and Metabolism, Metabolism, Diabetes, and Cancer. 286 papers and 50.1k citations.

PubIndex Score98Top 2%How it's scored

🌟#3 Current Senior Leader in 14-3-3 protein interactions

286Publications

50.1kTotal Citations

#3in 14-3-3 protein interactions

First publication: 1994First senior author: 2008

Lung Cancer Treatments and Mutations Cancer, Hypoxia, and Metabolism Metabolism, Diabetes, and Cancer RNA modifications and cancer Pancreatic function and diabetes

Top publicationsby citations

Induction of lysosomal and mitochondrial biogenesis by AMPK phosphorylation of FNIP1

Nazma Malik, Reuben J. Shaw|Science|2023

Cited by 197

Identification of AMPK Phosphorylation Sites Reveals a Network of Proteins Involved in Cell Invasion and Facilitates Large-Scale Substrate Prediction

Bethany E. Schaffer, Anne Brunet, Pablo E. Hollstein et al.|Cell Metabolism|2015

Cited by 184

Regulation of the Neurofibromatosis Type 2 Tumor Suppressor Protein, Merlin, by Adhesion and Growth Arrest Stimuli

Reuben J. Shaw, Tyler Jacks|Journal of Biological Chemistry|1998

Cited by 131

HDAC3 is critical in tumor development and therapeutic resistance in <i>Kras</i> -mutant non–small cell lung cancer

Lillian J. Eichner, Reuben J. Shaw|Science Advances|2023

Cited by 71

Raptor is Phosphorylated by cdc2 during Mitosis

Dana M. Gwinn, Reuben J. Shaw|PLoS ONE|2010

Cited by 63